Reid Robison

Reid Robison General Information

Description

Dr. Reid Robison serves as Chief Medical Officer and Director at Novamind Ventures. He serves as Co-Founder & Medical Director at Cedar Psychiatry. He is a Co-Founder and serves as Board Member & Chief Executive Officer at Tute Genomics. He also serves as Board Member at PierianDx. He was previously a coordinating investigator for the MAPS-sponsored MDMA-assisted psychotherapy study of eating disorders. He is a board-certified psychiatrist, with fellowship training in both neurodevelopmental genetics and bioinformatics. After residency and fellowship training at the University of Utah, he joined as tenure track faculty where he co-directed a molecular genetics lab, studying the genetic basis of autism and other neurodevelopmental disorders, using next-generation sequencing technology. He has led over $10 million in pharmaceutical studies, and previously founded Clinical Methods, an innovative, data-driven Phase I-IV CNS trials site that was later acquired. He is also co-founder of Anolinx, a healthcare data analytics firm that was acquired in 2012. As a social entrepreneur, he has built a number of purpose-driven companies including Tute Genomics which was acquired by PierianDx in 2016. He is also an adjunct professor at both the University of Utah and Brigham Young University and is the founder of the Polizzi Free Clinic, a free mental health clinic for marginalized people based in Salt Lake City, Utah.